OVERVIEW

European Association for the Study of the Liver (EASL) Liver Cancer Summit 2025 is organized by European Association for the Study of the Liver (EASL), Congrex Switzerland Ltd. and will be held from Feb 20 - 22, 2025 at The Issy Congress Center, Paris, Ile-de-France, France.

Description:
The premier event for liver cancer research and practice. Recent advancements in primary liver cancer, particularly in treatment strategies for hepatocellular carcinoma and cholangiocarcinoma, have transformed the field. Immunotherapy and new systemic therapies are challenging established treatment paradigms, while artificial intelligence is enhancing diagnostic capabilities. With rapid innovations and new therapeutic targets emerging, this summit is essential for staying at the forefront of liver cancer research and treatment.

The 2025 EASL Liver Cancer Summit in Paris will cover the latest advancements in liver cancer research and treatment. Day 1 highlights include a focus on Cholangiocarcinoma, innovative technologies in cancer pathogenesis, and the benefits and limitations of the LI-RADS system for diagnosing liver lesions.

Day 2 delves into systemic therapies for challenging HCC cases, the current treatment landscape for Cholangiocarcinoma, and experimental models in liver cancer research. It also explores the transformative potential of artificial intelligence in patient care. Day 3 emphasizes multidisciplinary patient care and reviews new EASL guidelines for HCC management, emerging drug treatments, and innovative approaches to liver transplantation.